BAY-184 is a selective oral inhibitor of KAT6A and KAT6B with IC50 values of 71 nM and 83 nM, respectively. This compound suppresses estrogen receptor α (ERα) transcriptional activity and impedes cell proliferation across various breast cancer subtypes as well as tumor growth.
Citations
No citations are currently available for this product. Below are selected publications citing GlpBio products.Description
Product Documents
Purity:>98.50%Appearance:A solid
Chemical Properties
CAS No.
2520347-03-7
Synonyms
BAY184
Molecular Formula
C23H20N2O4S
Molecular Weight
420.48
Solubility
DMSO: 95 mg/mL (225.93 mM), Sonication is recommended.
Storage
-20°C
Shipping Condition
Evaluation samples are shipped with blue ice. Other available sizes are shipped at room temperature or with blue ice upon request.
CalculatorsMolarity / Dilution / Molecular Weight / Unit Conversion / In Vivo Formulation / Solubility
g/mol
Reviews
Review for BAY-184
Rating: 5
- 5 Star100%
- 4 Star0%
- 3 Star0%
- 2 Star0%
- 1 Star0%
















